Associated Papers
Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair Deficient and/or POLE-Mutant Endometrial Carcinomas with TP53 Mutation.
Wang J et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2025
Traditional and New Views on MSI-H/dMMR Endometrial Cancer.
Liu C et al.
Biomolecules, 2025
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants.
Villy MC et al.
Gynecologic Oncology Reports, 2021
Select a paper to view details